Literature DB >> 18215354

Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma.

Ning Xu1, Hang-ping Yao, Zhen Sun, Zhi Chen.   

Abstract

AIM: The aim of the present study was to investigate the expression of Toll-like receptors (TLR) 7 and 9 in peripheral blood mononuclear cells (PBMC) of patients with chronic hepatitis B virus (HBV) infection and related hepatocellular carcinoma.
METHODS: The study group was comprised of 52 patients: 41 with chronic hepatitis B and 11 healthy controls. The protein and mRNA levels of TLR7 and TLR9 were evaluated using real-time PCR, Western blot analysis, and flow cytometry. We also detected the serum viral load of HBV in the patients and analyzed the correlation between HBV-DNA copies and the TLR expression.
RESULTS: Our results demonstrated a lower TLR7 expression in all HBV infection groups compared to the controls. We found that HBV infection led to a decreased expression of TLR9 mRNA, but an increased expression of the TLR9 protein compared to the healthy group. The TLR protein levels are related to serum HBV-DNA (P<0.01).
CONCLUSION: There are downregulations of TLR7 expression and TLR9 mRNA in PBMC of HBV-infected patients, but an increased TLR9 expression at the protein level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18215354     DOI: 10.1111/j.1745-7254.2008.00711.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  16 in total

1.  Toll-like receptor and innate cytokine responses induced by lactobacilli colonization and human rotavirus infection in gnotobiotic pigs.

Authors:  Ke Wen; Marli S P Azevedo; Ana Gonzalez; Wei Zhang; Linda J Saif; Guohua Li; Ahmed Yousef; Lijuan Yuan
Journal:  Vet Immunol Immunopathol       Date:  2008-10-31       Impact factor: 2.046

2.  TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.

Authors:  Cecilia Martínez-Campos; Margarita Bahena-Román; Kirvis Torres-Poveda; Ana I Burguete-García; Vicente Madrid-Marina
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-17       Impact factor: 4.553

Review 3.  Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity.

Authors:  Xia Jiang; Tatsuo Kanda; Shuang Wu; Masato Nakamura; Tatsuo Miyamura; Shingo Nakamoto; Arup Banerjee; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 4.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 5.  Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?

Authors:  Jorge André Gomes Lopes; Marta Borges-Canha; Pedro Pimentel-Nunes
Journal:  World J Hepatol       Date:  2016-01-28

6.  Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma.

Authors:  Zhong-Jun Wu; Yu Zhu; De-Rong Huang; Zhi-Qiang Wang
Journal:  J Exp Clin Cancer Res       Date:  2010-11-16

7.  HIV Infection and TLR Signalling in the Liver.

Authors:  Megan Crane; Kumar Visvanathan; Sharon R Lewin
Journal:  Gastroenterol Res Pract       Date:  2012-02-22       Impact factor: 2.260

8.  The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility.

Authors:  Xie Junjie; Jiang Songyao; Shi Minmin; Song Yanyan; Shen Baiyong; Deng Xiaxing; Jin Jiabin; Zhan Xi; Chen Hao
Journal:  BMC Cancer       Date:  2012-02-07       Impact factor: 4.430

9.  Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms.

Authors:  Ling Yang; Ekihiro Seki
Journal:  Front Physiol       Date:  2012-05-22       Impact factor: 4.566

10.  Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines.

Authors:  Yuzheng Huang; Bing Cai; Ming Xu; Zhiqin Qiu; Yonghui Tao; Ying Zhang; Jie Wang; Yongliang Xu; Yonghua Zhou; Jing Yang; Xiaofeng Han; Qi Gao
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.